Maristela Precivale
Libbs (Brazil)(BR)
Publications by Year
Research Areas
Meta-analysis and systematic reviews, Lung Cancer Treatments and Mutations, Statistical Methods in Clinical Trials, Biosimilars and Bioanalytical Methods, Lung Cancer Research Studies
Most-Cited Works
- → Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2(2013)237 cited
- → A randomized phase III trial of single-agent pemetrexed (P) versus carboplatin and pemetrexed (CP) in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2.(2012)27 cited
- → Sample Size Calculation in Oncology Trials(2014)14 cited
- → Abstract OT2-01-05: A prospective real-world national study to evaluate the efficacy and safety of adjuvant biosimilar trastuzumab in the treatment of HER2-positive breast cancer(2020)1 cited
- → Extrapolation of indications and drug interchangeability as barriers to use trastuzumab-dkst biosimilar in Brazil.(2020)
- → The Quality of Sample Size Calculation (SSC) Reporting in Cancer Clinical Trials(2012)